JPRN-jRCT2080224141已完成3 期
A Multicenter, Long-Term Extension to Evaluate the Long-Term Safety and Maintenance of Treatment Effect of Mirikizumab in Patients with Moderate-to-Severe Plaque Psoriasis(OASIS-3)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participant must have completed the last visit of an eligible study period of originating study.
- •- Participant must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential.
排除标准
- •- Participant must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematologic, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study.
- •- Participant must not have stopped taking mirikizumab during a previous study if the study investigator does not think the participant should resume taking mirikizumab.
研究者
相似试验
进行中（未招募）
1 期
A Phase 3 Trial in Moderate to Severe Plaque Psoriasis PatientsEUCTR2017-003299-30-GBEli Lilly and Company1,793
进行中（未招募）
1 期
A Phase 3 Trial in Moderate to Severe Plaque Psoriasis PatientsEUCTR2017-003299-30-ESilly S.A.1,793
进行中（未招募）
1 期
A Phase 3 Trial in Moderate to Severe Plaque Psoriasis PatientsModerate to severe plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2017-003299-30-PLEli Lilly and Company1,793
进行中（未招募）
1 期
A Phase 3 Trial in Moderate to Severe Plaque Psoriasis PatientsModerate to severe plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2017-003299-30-ITELI LILLY & COMPANY, LILLY CORPORATE CENTER1,793
进行中（未招募）
1 期
A Phase 3 Trial in Moderate to Severe Plaque Psoriasis PatientsModerate to severe plaque psoriasisMedDRA version: 20.0 Level: LLT Classification code 10071117 Term: Plaque psoriasis System Organ Class: 100000004858EUCTR2017-003299-30-FREli Lilly and Company1,793